Equillium (EQ) R&D In Process (2022)
Equillium (EQ) has disclosed R&D In Process for 1 consecutive years, with $23.0 million as the latest value for Q1 2022.
- Quarterly R&D In Process changed N/A to $23.0 million in Q1 2022 from the year-ago period, while the trailing twelve-month figure was $23.0 million through Dec 2022, changed N/A year-over-year, with the annual reading at $23.0 million for FY2022, N/A changed from the prior year.
- R&D In Process for Q1 2022 was $23.0 million at Equillium.
- The five-year high for R&D In Process was $23.0 million in Q1 2022, with the low at $23.0 million in Q1 2022.